Your browser is no longer supported. Please, upgrade your browser.
Settings
ZYNE Zynerba Pharmaceuticals, Inc. daily Stock Chart
ZYNE [NASD]
Zynerba Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.50 Insider Own13.78% Shs Outstand22.21M Perf Week10.15%
Market Cap149.47M Forward P/E- EPS next Y-1.88 Insider Trans0.00% Shs Float20.29M Perf Month-19.30%
Income-30.00M PEG- EPS next Q-0.51 Inst Own42.20% Short Float23.07% Perf Quarter-38.59%
Sales0.09M P/S1738.06 EPS this Y-5.20% Inst Trans10.60% Short Ratio6.51 Perf Half Y-48.94%
Book/sh3.67 P/B1.83 EPS next Y-22.10% ROA-36.10% Target Price21.50 Perf Year39.34%
Cash/sh3.49 P/C1.93 EPS next 5Y- ROE-40.50% 52W Range2.75 - 16.47 Perf YTD126.60%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-59.14% Beta4.70
Dividend %- Quick Ratio10.10 Sales past 5Y- Gross Margin- 52W Low144.73% ATR0.48
Employees25 Current Ratio10.10 Sales Q/Q- Oper. Margin- RSI (14)45.08 Volatility6.36% 6.89%
OptionableYes Debt/Eq0.00 EPS Q/Q82.20% Profit Margin- Rel Volume0.72 Prev Close6.55
ShortableYes LT Debt/Eq0.00 EarningsNov 14 BMO Payout- Avg Volume718.47K Price6.73
Recom1.90 SMA20-4.82% SMA50-14.57% SMA200-29.59% Volume538,414 Change2.75%
Oct-21-19Initiated Needham Buy $18
Apr-22-19Resumed Canaccord Genuity Buy
Feb-01-18Resumed H.C. Wainwright Buy $23
Jan-29-18Initiated Ladenburg Thalmann Buy $25.50
Jan-26-18Initiated Seaport Global Securities Buy $16
Oct-02-17Upgrade Cantor Fitzgerald Neutral → Overweight $4 → $17
Sep-29-17Upgrade Piper Jaffray Neutral → Overweight
Aug-15-17Upgrade ROTH Capital Neutral → Buy
Aug-15-17Downgrade Oppenheimer Outperform → Perform
Aug-15-17Downgrade Jefferies Buy → Hold
Aug-08-17Downgrade ROTH Capital Buy → Neutral
Aug-08-17Downgrade H.C. Wainwright Buy → Neutral $7
Aug-07-17Downgrade Piper Jaffray Overweight → Neutral
Aug-07-17Downgrade Maxim Group Buy → Hold
Aug-07-17Downgrade Cantor Fitzgerald Overweight → Neutral $28 → $4
Mar-28-17Reiterated H.C. Wainwright Buy $22 → $30
Feb-24-17Initiated Maxim Group Buy $32
Dec-22-16Initiated Cantor Fitzgerald Overweight $28
Dec-06-16Resumed Jefferies Buy
Oct-07-16Initiated H.C. Wainwright Buy $22
Nov-21-19 09:47AM  ZYNE ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. ZYNE GlobeNewswire
05:00AM  Zynerba- CBD and Transdermal Delivery MoneyShow
Nov-20-19 05:29PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Domo, Infosys, Zynerba, and iRobot and Encourages Investors to Contact the Firm GlobeNewswire
03:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline ZYNE GlobeNewswire
10:33AM  Bronstein, Gewirtz & Grossman, LLC Alerts Investors of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) ACCESSWIRE
Nov-19-19 10:58AM  Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm Newsfile
Nov-18-19 08:18PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE CNW Group
10:32AM  Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) ACCESSWIRE
Nov-16-19 08:43AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE ACCESSWIRE
Nov-15-19 03:00PM  Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) GlobeNewswire
10:48AM  Zynerba Pharmaceuticals Enters Oversold Territory Zacks
10:04AM  Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) ACCESSWIRE
09:57AM  Zynerba Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm Newsfile
Nov-13-19 06:45PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zynerba, iRobot, Zendesk, and PG&E Corporation and Encourages Investors to Contact the Firm GlobeNewswire
04:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ZYNE ACCESSWIRE
03:37PM  Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm Newsfile
01:35PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:56AM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. ZYNE GlobeNewswire
10:03AM  Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) ACCESSWIRE
Nov-12-19 07:00AM  Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Fragile X Syndrome with Transdermal Cannabidiol GlobeNewswire
Nov-11-19 06:44PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline ZYNE GlobeNewswire +5.91%
10:03AM  Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) ACCESSWIRE
Nov-08-19 04:27PM  Zhang Investor Law Announces Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. ZYNE GlobeNewswire
03:15PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
03:00PM  SHAREHOLDER ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 23, 2019 GlobeNewswire
09:26AM  SHAREHOLDER ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Deadline: December 23, 2019 ACCESSWIRE
Nov-07-19 01:45PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:30PM  ZYNERBA CLASS ACTION ALERT: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Zynerba Pharmaceuticals ACCESSWIRE
Nov-06-19 05:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zynerba, iRobot, Zendesk, and Abeona and Encourages Investors to Contact the Firm GlobeNewswire -5.47%
02:15PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
01:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE ACCESSWIRE
01:18PM  Does Zynerba Pharmaceuticals, Inc.'s (NASDAQ:ZYNE) CEO Pay Compare Well With Peers? Simply Wall St.
10:25AM  SHAREHOLDER ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Deadline: December 23, 2019 ACCESSWIRE
06:45AM  Zynerba Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights GlobeNewswire
Nov-05-19 03:30PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
08:33AM  Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm Newsfile
Nov-04-19 05:50PM  Zynerba Pharmaceuticals (ZYNE) Stock Sinks As Market Gains: What You Should Know Zacks
03:24PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline ZYNE GlobeNewswire
11:42AM  What's in the Cards for Zynerba (ZYNE) This Earnings Season? Zacks
10:24AM  SHAREHOLDER ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: December 23, 2019 ACCESSWIRE
Nov-01-19 03:20PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
03:00PM  INVESTOR ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 23, 2019 GlobeNewswire
01:21PM  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in TEUM, INFY, and ZYNE of Filing Deadlines GlobeNewswire
10:26AM  SHAREHOLDER ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Plaintiff Deadline: December 23, 2019 ACCESSWIRE
Oct-31-19 03:00PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:46AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE ACCESSWIRE
Oct-30-19 06:30PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
06:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Domo, Pareteum, Infosys, and Zynerba and Encourages Investors to Contact the Firm GlobeNewswire
04:10PM  ZYNERBA PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for Eastern District of Pennsylvania against Zynerba Pharmaceuticals, Inc. GlobeNewswire
10:24AM  SHAREHOLDER ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 23, 2019 ACCESSWIRE
Oct-29-19 04:10PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:01AM  SHAREHOLDER ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 23, 2019 PR Newswire
Oct-28-19 01:10PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
01:01PM  Shareholder Alert: Robbins Arroyo LLP Announces Zynerba Pharmaceuticals, Inc. (ZYNE) Sued for Misleading Shareholders Business Wire
10:42AM  ZYNERBA CLASS ACTION ALERT: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Zynerba Pharmaceuticals PR Newswire
10:22AM  INVESTOR ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 23, 2019 ACCESSWIRE
08:45AM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Oct-26-19 06:01PM  Top Marijuana Stocks on the NASDAQ Investopedia
05:22PM  From Medical CBD To Cannavore Edibles: 6 Cannabis Companies Make Investment Pitches Benzinga
Oct-25-19 02:00PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
01:45PM  Zynerba Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference GlobeNewswire
01:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE ACCESSWIRE
12:17PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:06PM  ZYNERBA CLASS ACTION ALERT: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Zynerba Pharmaceuticals Business Wire
11:28AM  ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. ZYNE Business Wire
Oct-24-19 06:06PM  ZYNERBA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Zynerba Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Business Wire
Oct-23-19 07:53PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Announces the Filing of a Class Action against Zynerba Pharmaceuticals, Inc. and Certain Officers ZYNE GlobeNewswire
Oct-15-19 02:00PM  Benzinga Announces: Zynerba Pharmaceuticals, Inc. Presenting at the Cannabis Capital Conference in Chicago Newsfile
Oct-08-19 03:56PM  Lifshitz & Miller LLP Announces Investigation of Church & Dwight Co., Fibrocell Science, Inc., MacroGenics, Inc., MINDBODY, Inc., PaySign, Inc., Zebra Technologies Corporation and Zynerbia Pharmaceuticals PR Newswire
Oct-02-19 05:50PM  Zynerba Pharmaceuticals (ZYNE) Stock Moves -1.43%: What You Should Know Zacks
Sep-26-19 11:50AM  Zynerba Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-25-19 09:52AM  Epidolex Progresses: Will the Marijuana Drug Market Boom? Zacks
Sep-23-19 03:26PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zynerba Pharmaceuticals - ZYNE GlobeNewswire
Sep-20-19 11:00AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Zynerba Pharmaceuticals (ZYNE) ACCESSWIRE
Sep-19-19 05:16PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zynerba Pharmaceuticals  ZYNE GlobeNewswire
10:29AM  Zynerba Releases Data on Epilepsy Candidate, Stock Down Zacks
Sep-18-19 09:34AM  Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE): A Fundamentally Attractive Investment Simply Wall St. -21.77%
09:30AM  Zynerba Plunges On Midstage Zygel Data In Epileptic Patients Benzinga
06:30AM  Zynerba Pharmaceuticals Announces Positive Top Line Data from BELIEVE 1 Open Label Phase 2 Study of Zygel in Developmental and Epileptic Encephalopathies (DEE) GlobeNewswire
Sep-17-19 05:01AM  Zynerba Stock is a Medical Cannabis Investment You Can Feel Good About InvestorPlace
Sep-11-19 10:47AM  14 Top Cannabis Stocks Targeted By Short Sellers Benzinga
Sep-03-19 11:30AM  Zynerba Pharmaceuticals to Present at Two Upcoming Conferences GlobeNewswire
Aug-29-19 07:30AM  Zynerba Pharmaceuticals Announces Poster Presentations at the 22nd Society for the Study of Behavioural Phenotypes (SSBP) Symposium GlobeNewswire
Aug-18-19 07:37AM  3 Healthcare Stocks to Fight Off the Market Flu TipRanks
Aug-08-19 10:57AM  When Can We Expect A Profit From Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE)? Simply Wall St.
Aug-07-19 06:33PM  Here's Why Zynerba Pharmaceuticals Lost 21.8% in July Motley Fool +13.09%
Aug-06-19 09:40AM  Zynerba (ZYNE) Meets Earnings Estimates in Q2, Revenues Nil Zacks +5.31%
08:00AM  Zynerba Pharmaceuticals Announces Publication of Zygel (ZYN002) 12-week Open Label Fragile X Syndrome Data in the Journal of Neurodevelopmental Disorders GlobeNewswire
06:45AM  Zynerba Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights GlobeNewswire
Jul-31-19 08:00AM  Zynerba Pharmaceuticals to Present at Two Upcoming Conferences GlobeNewswire
Jul-24-19 09:00AM  What's in the Cards for Zynerba (ZYNE) This Earnings Season? Zacks
Jul-23-19 09:42AM  Zynerba Pharma Looks Like Bad Medicine for Investors TheStreet.com -8.72%
07:41AM  Jim Cramer Weighs In On Berkshire Hathaway, Range Resources, Zynerba And More Benzinga
Jul-18-19 05:45PM  Zynerba Pharmaceuticals (ZYNE) Outpaces Stock Market Gains: What You Should Know Zacks
Jul-12-19 04:26PM  Here's Why Zynerba Pharmaceuticals Stock Soared 356% in the First Half of the Year Motley Fool -5.28%
07:15AM  5 Best Biotech Stocks of 2019 So Far Motley Fool
Jul-11-19 05:50PM  Zynerba Pharmaceuticals (ZYNE) Outpaces Stock Market Gains: What You Should Know Zacks
Jul-03-19 08:31AM  These Are the Only 15 Pot Stocks That Rose in the Second Quarter Motley Fool
Jul-02-19 05:50PM  Zynerba Pharmaceuticals (ZYNE) Outpaces Stock Market Gains: What You Should Know Zacks
06:03AM  Is Zynerba Pharmaceuticals's (NASDAQ:ZYNE) 102% Share Price Increase Well Justified? Simply Wall St.
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. The company is developing Zygel, a transdermal cannabidiol gel, which is in Phase II clinical trial for treating children and adolescent patients with developmental and epileptic encephalopathies; is in Phase II/III clinical trial to treat children and adolescent patients with fragile X syndrome; and is in Phase II clinical trial for treating children and adolescent patients with autism spectrum disorder. It is also developing ZYN001, a pro-drug of tetrahydrocannabinol. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Devon, Pennsylvania.